286 related articles for article (PubMed ID: 22826097)
1. Effect of early syphilis infection on plasma viral load and CD4 cell count in human immunodeficiency virus-infected men: results from the FHDH-ANRS CO4 cohort.
Jarzebowski W; Caumes E; Dupin N; Farhi D; Lascaux AS; Piketty C; de Truchis P; Bouldouyre MA; Derradji O; Pacanowski J; Costagliola D; Grabar S;
Arch Intern Med; 2012 Sep; 172(16):1237-43. PubMed ID: 22826097
[TBL] [Abstract][Full Text] [Related]
2. Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response.
Kofoed K; Gerstoft J; Mathiesen LR; Benfield T
Sex Transm Dis; 2006 Mar; 33(3):143-8. PubMed ID: 16505739
[TBL] [Abstract][Full Text] [Related]
3. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
4. Syphilis and neurosyphilis in human immunodeficiency virus-infected patients: a retrospective study at a teaching hospital in Taiwan.
Wang YJ; Chi CY; Chou CH; Ho CM; Lin PC; Liao CH; Ho MW; Wang JH
J Microbiol Immunol Infect; 2012 Oct; 45(5):337-42. PubMed ID: 22698630
[TBL] [Abstract][Full Text] [Related]
5. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
6. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
7. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
9. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
[TBL] [Abstract][Full Text] [Related]
10. Early syphilis affects markers of HIV infection.
Kotsafti O; Paparizos V; Kourkounti S; Chatziioannou A; Nicolaidou E; Kapsimali V; Antoniou C
Int J STD AIDS; 2016 Aug; 27(9):739-45. PubMed ID: 26113517
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
Wolbers M; Battegay M; Hirschel B; Furrer H; Cavassini M; Hasse B; Vernazza PL; Bernasconi E; Kaufmann G; Bucher HC;
Antivir Ther; 2007; 12(6):889-97. PubMed ID: 17926643
[TBL] [Abstract][Full Text] [Related]
12. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
[TBL] [Abstract][Full Text] [Related]
13. The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen.
Sadiq ST; McSorley J; Copas AJ; Bennett J; Edwards SJ; Kaye S; Kirk S; French P; Weller IV
Sex Transm Infect; 2005 Oct; 81(5):380-5. PubMed ID: 16199736
[TBL] [Abstract][Full Text] [Related]
14. Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts.
Nozza S; Canducci F; Galli L; Cozzi-Lepri A; Capobianchi MR; Ceresola ER; Narciso P; Libertone R; Castelli P; Moioli M; D'Arminio Monforte A; Castagna A;
J Antimicrob Chemother; 2012 May; 67(5):1224-7. PubMed ID: 22298348
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).
Tubiana R; Le Chenadec J; Rouzioux C; Mandelbrot L; Hamrene K; Dollfus C; Faye A; Delaugerre C; Blanche S; Warszawski J
Clin Infect Dis; 2010 Feb; 50(4):585-96. PubMed ID: 20070234
[TBL] [Abstract][Full Text] [Related]
16. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
[TBL] [Abstract][Full Text] [Related]
17. Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients.
Palacios R; Jiménez-Oñate F; Aguilar M; Galindo MJ; Rivas P; Ocampo A; Berenguer J; Arranz JA; Ríos MJ; Knobel H; Moreno F; Ena J; Santos J
J Acquir Immune Defic Syndr; 2007 Mar; 44(3):356-9. PubMed ID: 17159654
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109).
Launay O; Duval X; Dalban C; Descamps D; Peytavin G; Certain A; Mouajjah S; Ralaimazava P; Verdon R; Costagliola D; Clavel F;
Antivir Ther; 2006; 11(7):889-99. PubMed ID: 17302251
[TBL] [Abstract][Full Text] [Related]
20. Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
Lohse N; Kronborg G; Gerstoft J; Larsen CS; Pedersen G; Pedersen C; Sørensen HT; Obel N
Clin Infect Dis; 2006 Jan; 42(1):136-44. PubMed ID: 16323104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
